세계의 급성 폐손상 치료 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

The global demand for Acute Lung Injury Treatment Market is presumed to reach the market size of nearly USD 9.27 BN by 2030 from USD 6.22 BN in 2022 with a CAGR of 5.12% under the study period 2022 - 2030.

Acute Lung Injury (ALI) is a condition in which the lungs become severely inflamed, leading to fluid accumulation in the lungs and impaired gas exchange. ALI is a medical emergency that requires immediate treatment. The treatment of ALI is aimed at managing the underlying cause of the condition and providing supportive care to improve lung function and oxygenation. The treatment of ALI is complex, and the approach may vary depending on the severity of the condition and the underlying cause. Close monitoring and management of ALI are crucial to improve outcomes and prevent complications.

Market Dynamics:

The rising prevalence of ALI, especially among critically ill patients, is a major driver of the ALI treatment market. The increasing incidence of ALI is primarily due to the aging population, increased prevalence of chronic diseases, and higher rates of hospitalization. Technological advancements have significantly improved the diagnosis and treatment of ALI. The new therapeutic agents development, such as anti-inflammatory drugs and immunomodulatory agents, has led to more effective and targeted treatments for ALI. Governments and regulatory bodies worldwide are investing heavily in the development of new treatments for ALI. This funding is driving research and development efforts in the field, leading to the development of new and innovative therapies.Healthcare professionals are becoming more aware of the potential risks and consequences of ALI, leading to earlier diagnosis and treatment. This awareness is driving the demand for ALI treatment. The demand for non-invasive ventilation techniques, such as continuous positive and bi-level positive airway pressure is increasing. These techniques are preferred over invasive mechanical ventilation, which can cause complications such as infections and lung injury. Growing focus on personalized medicine: Personalized medicine is gaining popularity in the ALI treatment market. This approach involves tailoring treatments to the individual patient, taking into account their genetic makeup, medical history, and other factors. Personalized medicine is expected to lead to more effective and targeted treatments for ALI.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acute lung injury treatment. The growth and trends of acute lung injury treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the acute lung injury treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

• Mechanical Ventilation
• Pharmacotherapy
• Fluid Management
• Others

By End-User

• Hospitals
• Specialty Centers
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Acute Lung Injury Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the acute lung injury treatment market include Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, Aster Hospitals, Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ACUTE LUNG INJURY TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Therapy
  • 3.7.2 Market Attractiveness Analysis By End-User
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY THERAPY

• 6.1 Overview by Therapy
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Therapy
• 6.4 Mechanical Ventilation Historic and Forecast Sales by Regions
• 6.5 Pharmacotherapy Historic and Forecast Sales by Regions
• 6.6 Fluid Management Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-User
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-User
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Specialty Centers Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ACUTE LUNG INJURY TREATMENT COMPANIES

• 9.1. Acute Lung Injury Treatment Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ACUTE LUNG INJURY TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Mayo Clinic
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Johns Hopkins Hospital
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Cleveland Clinic
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Great Ormond Street Hospital
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Apollo Hospitals
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Tokyo Medical University Hospital
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. The Prince Charles Hospital
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Helios Hospital
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Aster Hospitals
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Other
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies